G
Glenmark Pharmaceuticals Ltd
Pharmaceuticals
MIDCAP
Pharmaceuticals
Live Performance vs
This is a tool to communicate factual return information and should not be seen as an advertisement or promotion
| Key Metrics | This Stock | Category (Avg) |
| PE Ratio | -26.77 | 46.01 |
| PB Ratio | 4.09 | 6.09 |
| Dividend Yield | 0.18% | 0.55% |
Understand what these metrics mean.
About the company
G
Glenmark Pharmaceuticals Ltd
Glenmark Pharmaceuticals Limited is a global pharmaceutical company engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs).
Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions